Moreover, the results of the study showed a 12 percent reduction in deaths among patients who were dispensed satins such as Zocor but who did not possess any recognized cardiovascular disease and suffered from other risk factors. The study had continued for 4 years and during this period, the Zocor group had fewer heart attacks and fewer strokes. Another amazing finding of the study was that there were no noteworthy treatment disparities between men and women, young and aged patients, and patients with and without diabetes. There was also no proof of an increased danger of cancer with satin therapy.

Zocor (Simvastatin) has made long strides in the treatment hypercholesterolemia (increased cholesterol levels) and cardiovascular diseases since its introduction to the market in the late 1980s. Merck & Co first developed and marketed this medication under the brand name Zocor. But, it is now widely available in generic form in majority of countries after the US patent expiry for Zocor on June 23, 2006. Before the patent expiry, Zocor (Simvastatin) used to be Merck & Co’s highest selling drug and the second highest selling cholesterol lowering drug in the world. It was also the first satin medication to be employed comprehensively in clinical practices. The above study has now confirmed that patients without an established cardiovascular disease or elevated cholesterol level can also derive benefit from Zocor if they have one or more risk factors for this disease such as diabetes mellitus, high blood pressure, or a positive family history.

Simvastatin is a potent cholesterol-lowering drug and can reduce low density lipoprotein (LDL) levels by up to 50 percent. Patients can be recommended doses between 5mg and 80mg. There is also a higher dose of 160mg that has been observed to be excessively toxic. It also provides minimum benefit in terms of lowering your cholesterol or triglyceride level. Recent research on Simvastatin and other statin drugs proves their effectiveness in blocking the advancement of atherosclerosis that involves fatty deposits inside the arterial walls, therefore shrinking the arteries. There also certain explanations regarding its inhibitory outcome on macrophages in the atherosclerotic plaque wounds.

Zocor (Simvastatin) is orally dispensed with a full glass of water and its pills or tablets are available in 5, 10, 20, and 40 mg of Simvastatin. The drug is most effective only when it is taken at bedtime or with an evening meal. Multiple doses of Zocor per day must be taken with meals. Take exact amount of the drug as prescribed by your healthcare provider.